Deals
Every acquisition, merger, IPO, and funding round — published the day it happens.
SpaceX targets IPO amid Starlink valuation scrutiny and revenue challenges
SpaceX is positioning Starlink for an IPO as it grapples with sustaining profit growth amidst declining user revenue. The move raises questions about Starlink's market valuation and future financial performance against increasing competition.
- Satellite internet firms face valuation pressure and heightened investor expectations
- Potential IPO invites scrutiny on sustainability of Starlink's revenue model
- Competitors may capitalize on perceived weaknesses in Starlink's user growth strategy
Johnson & Johnson acquires Firefly Bio, Inc. for $1 billion, enhancing its oncology pipeline with Firefly's degrader antibody conjugate platform.
Wellington Management has acquired Hartford Funds for $1.9 billion, expanding its footprint in the investment management sector.
Incyte Corporation has agreed to acquire biotech firm Vega Therapeutics for $2 billion, aiming to enhance its therapeutic offerings in the sector.
Acquisitions
SpaceX targets IPO amid Starlink valuation scrutiny and revenue challenges
SpaceX is positioning Starlink for an IPO as it grapples with sustaining profit growth amidst declining user revenue. The move raises questions about Starlink's market valuation and future financial performance against increasing competition.
GSK has agreed to acquire Nuvalent in a $10.6 billion transaction. The deal includes the acquisition of Nuvalent's two cancer drug candidates currently under FDA review, expanding GSK's portfolio in oncology.
Johnson & Johnson acquires Firefly Bio, Inc. for $1 billion, enhancing its oncology pipeline with Firefly's degrader antibody conjugate platform.
Wellington Management has acquired Hartford Funds for $1.9 billion, expanding its footprint in the investment management sector.
Mergers
Treeline Biosciences Merges with Standard BioTools for $900M
Treeline Biosciences has merged with Standard BioTools in a $900 million deal to gain public market access and bolster its operational capabilities with enhanced financial strength.
Fundraising
PhysicsX Secures $300M Series C Funding
London-based PhysicsX Ltd. has raised $300 million in a Series C round led by Temasek to enhance its AI-driven hardware design platform.
Every deal that matters, 7:00 a.m. Eastern.
Acquisitions, mergers, IPOs, and funding rounds — curated by our analyst desk. The one email corp dev, M&A bankers, and strategy teams read before their morning calls.